ID   JMRD3
AC   CVCL_D592
DR   Wikidata; Q54899010
RX   PubMed=7994044;
RX   PubMed=8635507;
CC   Selected for resistance to: ChEBI; CHEBI_73558; Vitamin D3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D591 ! RWLeu-4
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 12
//
RX   PubMed=7994044; DOI=10.1182/blood.V84.12.4283.bloodjournal84124283;
RA   Lasky S.R., Posner M.R., Iwata K., Santos-Moore A., Yen A., Samuel V.,
RA   Clark J.W., Maizel A.L.;
RT   "Characterization of a vitamin D3-resistant human chronic myelogenous
RT   leukemia cell line.";
RL   Blood 84:4283-4294(1994).
//
RX   PubMed=8635507; DOI=10.1006/excr.1996.0165;
RA   Iwata K., Kouttab N., Ogata H., Morgan J.W., Maizel A.L., Lasky S.R.;
RT   "Differential regulation of vitamin D receptors in clonal populations
RT   of a chronic myelogenous leukemia cell line.";
RL   Exp. Cell Res. 225:143-150(1996).
//